Related references
Note: Only part of the references are listed.A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes
J. M. Eggington et al.
CLINICAL GENETICS (2014)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Marcia Irene Canto et al.
GUT (2013)
Current Evidence on the Relationship Between Two Polymorphisms in the NBS1 Gene and Breast Cancer Risk: a Meta-analysis
Zhi-Hua Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
Magdalena Ratajska et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Min-Han Tan et al.
CLINICAL CANCER RESEARCH (2012)
Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families
Ana Osorio et al.
HUMAN MOLECULAR GENETICS (2012)
Rare germline mutations in PALB2 and breast cancer risk: A population-based study
Marc Tischkowitz et al.
HUMAN MUTATION (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Germline RAD51C mutations confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2012)
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Silvia Casadei et al.
CANCER RESEARCH (2011)
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
Konstantin J. Dedes et al.
CELL CYCLE (2011)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Germline PALB2 mutation analysis in breast-pancreas cancer families
Zsofia K. Stadler et al.
JOURNAL OF MEDICAL GENETICS (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
Victoria J. Weston et al.
BLOOD (2010)
Cancer Predisposing Missense and Protein Truncating BARD1 Mutations in Non-BRCA1 or BRCA2 Breast Cancer Families
Sylvia De Brakeleer et al.
HUMAN MUTATION (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl et al.
NATURE GENETICS (2010)
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A PALB2 mutation associated with high risk of breast cancer
Melissa C. Southey et al.
BREAST CANCER RESEARCH (2010)
Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
Sylvie Desjardins et al.
BMC CANCER (2009)
The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
Tuomas Heikkinen et al.
CLINICAL CANCER RESEARCH (2009)
Increased Colorectal Cancer Incidence in Obligate Carriers of Heterozygous Mutations in MUTYH
Natalie Jones et al.
GASTROENTEROLOGY (2009)
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Kelly D. Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007
C. Sue Richards et al.
GENETICS IN MEDICINE (2008)
CHEK2* 1100delC genotyping for clinical assessment of breast cancer risk:: Meta-analyses of 26,000 patient cases and 27,000 controls
Maren Weischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nijmegen BREAKAGE SYNDROME mutations and risk of breast cancer
Natalia Bogdanova et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cancer risk of heterozygotes with the NBN founder mutation
Eva Seemanov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer
Pardeep Kaurah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Sheila Seal et al.
NATURE GENETICS (2006)
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
Anthony Renwick et al.
NATURE GENETICS (2006)
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome
Nicholas Hearle et al.
CLINICAL CANCER RESEARCH (2006)
Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations:: A population-based case-family study
MA Jenkins et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Cancer risks and mortality in heterozygous ATM mutation carriers
D Thompson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Relative frequency and morphology of cancers in STK11 mutation carriers
W Lim et al.
GASTROENTEROLOGY (2004)
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer et al.
NATURE GENETICS (2002)
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2:: Analysis of 10,000 individuals
TS Frank et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families
PDP Pharoah et al.
GASTROENTEROLOGY (2001)
Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome
JM Limacher et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
